Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04541732
Other study ID # MS /18.06.187
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date May 6, 2019

Study information

Verified date September 2020
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute postoperative pain is an important issue after major abdominal surgeries for which different analgesic modalities have been tried.

Epidural analgesia is the recommended technique to relieve pain after major abdominal surgeries owing to the proved superior analgesia, reduction of opioid-related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility. However, it is not without complications.

Quadratus lumborum block is an ultrasound-guided block that provides patients with both visceral and somatic blockade. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for analgesia after major abdominal surgeries.


Description:

The aim of this study is to detect the feasibility of ultra-sound guided bilateral quadratus lumborum block as a postoperative analgesic modality after major abdominal surgery in comparison to epidural block and its effects on total rescue analgesic requirements in the 1st postoperative 24hours, time to first analgesic request, pain VAS scores, intraoperative and postoperative hemodynamics and postoperative opioid-related side effects.

Under complete aseptic conditions, the patients will receive either thoracic epidural block or bilateral ultrasound-guided quadratus lumborum block after induction of general anaesthesia


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date May 6, 2019
Est. primary completion date April 9, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria:

- Patient's refusal

- Significant cardiac, disease.

- Significant hepatic disease.

- Significant renal disease (serum creatinine ? 1.5 mg/dl).

- Patients with drug abuse

- Allergy to study medications

- Mental disease

- Communication barrier.

- Coagulopathy.

- Local skin infection

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Thoracic epidural block
Patients who will be subjected to epidural block will be placed in the lateral position then, after sterilization of the skin, 21 G spinal needle will be inserted at T9-T11 intervertebral spaces. The epidural space will be located using the loss of resistance to air technique and a mixture of bupivacaine 0.25% + 50 µ fentanyl targeting T6 level will be injected following induction of general anaesthesia.
Ultrasound-guided bilateral quadratus lumborum block
Patients who will be subjected to major abdominal surgeries will be placed in a supine position with a pillow under their side to obtain an appropriate view of quadratus lumborum muscle. After sterilization of the skin and ultrasound-guided identification of the quadratus lumborum muscle, 20 ml bupivacaine 0.25% + 25µ fentanyl will be injected on each side following induction of general anaesthesia
Drug:
Induction of general anaesthesia with propofol
propofol: 1.5-2.5mg/Kg
Muscle Relaxant
Atracurium : 0.5mg/Kg.
Maintenance of general anaesthesia
Sevoflurane 0.7-1.5 MAC in 40% oxygen

Locations

Country Name City State
Egypt Mohammed A Ghanem Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative 24 hours cumulative rescue morphine consumption For 24 hours after surgery
Secondary The duration of postoperative analgesia time from performing epidural or quadratus lumborum block till the time for the first rescue morphine request For 24 hours after surgery
Secondary Postoperative pain score at rest Visual analogue scale to assess the severity of postoperative pain (0 mm for no pain and100 mm for worst imaginable pain) For 24 hours after surgery
Secondary Postoperative pain score on movement Visual analogue scale to assess the severity of postoperative pain (0 mm for no pain and100 mm for worst imaginable pain) For 24 hours after surgery
Secondary Postoperative pain score on cough Visual analogue scale to assess the severity of postoperative pain (0 mm for no pain and100 mm for worst imaginable pain) For 24 hours after surgery
Secondary Systolic blood pressure For 28 hours after induction of anesthesia
Secondary Diastolic blood pressure For 28 hours after induction of anesthesia
Secondary Mean blood pressure For 28 hours after induction of anesthesia
Secondary Heart rate For 28 hours after induction of anesthesia
Secondary Degree of postoperative nausea and vomiting Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3). The number of vomiting episodes and the number of antiemetics received will be recorded For 24 hours after surgery
Secondary Pruritis For 24 hours after surgery
See also
  Status Clinical Trial Phase
Completed NCT01387568 - Lidocaine Infusion for Major Abdominal Pediatric Surgery Phase 3
Recruiting NCT06182215 - PostoperAtive Neurocognitive Dysfunction After Major AbdomiNal Surgery (PANDAMAN)